Helene Chaumont

Helene Chaumont has extensive work experience in regulatory and product safety roles. Helene worked at Puressentiel France as the Regulatory, Products Safety, and Quality Director, where they managed and evaluated raw materials and finished products files. Helene also had experience in worldwide regulatory monitoring and the development of products. Prior to that, they worked at L'Occitane Group as the Regulatory and Products Safety Director, where they managed and evaluated raw materials and finished products files and oversaw regulatory monitoring for all group products. Helene also managed teams and implemented departmental growth. Other notable positions they held include Technical-Regulatory Assessor at ANSM Agence nationale de sécurité du médicament et des produits de santé, Pharmacist at MSD in regulatory affairs, and Pharmacist at Agence Générale des Équipements et Produits de Santé (AGEPS) AP-HP in drug production. Helene also had experience in clinical trials and quality as a pharmacist at Hotel Dieu Hospital and as a Resident at Lucile Packard's Children Hospital, Stanford University Medical Center.

Helene Chaumont has a diverse education history with a focus on health and pharmaceuticals. In 2005, they conducted a pharmaceutical thesis at the University of Pharmacy in Paris XI. During the same year, they also completed an internship at the University of Pharmacy in Paris XI, with specialization in the industrial and biomedical aspects of pharmacy. In 2004, they obtained a degree in CESAM - Statistic: Validation Clinical Trials from the Centre of Applied Statistics in Medicine and Biology - Inserm. In 2003, they attained a Master's degree in Pharmaceutical Economy and European Legislation of Health Products from the University of Pharmacy in Lille. Their education continued in 2002, when they started their studies at the University of Pharmacy in Marseille, focusing on CEU Toxicology and Cosmetic Products. In 2010, they pursued a degree in Safety Assessment of Cosmetics at the Vrije Universiteit Brussel. In 2013, they completed a short program on the Safety Assessment of Cosmetics EU Follow-up, also at the Vrije Universiteit Brussel.